Neurodegeneration and inflammation in Parkinson's disease.

[1]  C. Moussa,et al.  Inflammation in the early stages of neurodegenerative pathology , 2011, Journal of Neuroimmunology.

[2]  E. Hirsch,et al.  Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism , 2011, Proceedings of the National Academy of Sciences.

[3]  G. Halliday,et al.  Glia: Initiators and progressors of pathology in Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[4]  P. Whitton.  Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease. , 2010, Current opinion in investigational drugs.

[5]  C. Long-Smith,et al.  The influence of microglia on the pathogenesis of Parkinson's disease , 2009, Progress in Neurobiology.

[6]  H. Neumann,et al.  Microglial clearance function in health and disease , 2009, Neuroscience.

[7]  E. Hirsch,et al.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.

[8]  A. Hofman,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease , 2007, Neuroepidemiology.

[9]  W. Cass,et al.  GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease , 2007, Neuroscience Letters.

[10]  S. Przedborski.  Neuroinflammation and Parkinson's disease. , 2007, Handbook of clinical neurology.

[11]  Hideyuki Okano,et al.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury , 2006, Nature Medicine.

[12]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[13]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. , 2003, Nature medicine.

[14]  G. Donnan,et al.  Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge , 2002, Molecular and Cellular Neuroscience.

[15]  B. Rosen,et al.  NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals , 1996, Brain Research.

[16]  L. Olson,et al.  Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo , 1995, Nature.

[17]  J. Langston,et al.  Chapter 36: Astrocytes and Parkinson's disease , 1992 .

[18]  J. Langston,et al.  Astrocytes and Parkinson's disease. , 1992, Progress in brain research.

[19]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[20]  T. Nagatsu.  [Biochemistry of Parkinson's disease]. , 1988, Seikagaku. The Journal of Japanese Biochemical Society.